Wolverine Trading’s Core Laboratories CLB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q1
Sell
-10,996
Closed -$308K 4688
2019
Q4
$522K Buy
10,996
+6,178
+128% +$278K ﹤0.01% 3031
2019
Q3
$221K Sell
4,818
-6,327
-57% -$294K ﹤0.01% 3470
2019
Q2
$583K Buy
+11,145
New +$654K ﹤0.01% 2554
2018
Q4
Sell
-9,016
Closed -$1.04M 4518
2018
Q3
$1.04M Buy
9,016
+4,428
+97% +$500K ﹤0.01% 2312
2018
Q2
$497K Hold
4,588
﹤0.01% 3115
2018
Q1
$497K Buy
+4,588
New +$508K ﹤0.01% 3115
2016
Q4
Sell
-3,291
Closed -$364K 4496
2016
Q3
$364K Buy
+3,291
New +$379K ﹤0.01% 2970

Other funds holding CLB

Wolverine Trading's CLB Position: Q1 2020 in Review

Wolverine Trading sold out of Core Laboratories (CLB) in Q1 2020, closing a stake of 10,996 shares — an estimated $308K sold.

Wolverine Trading first reported a position in CLB in Q3 2016 and held it in 7 quarters. The position peaked at $1.04M in Q3 2018. 207 funds tracked by Wall St. Rank hold CLB as of Q1 2020.

  • Wolverine Trading reported no remaining Core Laboratories position as of Q1 2020 after selling out during the quarter.
  • Wolverine Trading sold 10,996 Core Laboratories shares in Q1 2020, an estimated $308K.
  • Wolverine Trading first reported a position in Core Laboratories in Q3 2016 and held it in 7 quarters.
  • Wolverine Trading's Core Laboratories position peaked at $1.04M in Q3 2018.
  • 207 funds tracked by Wall St. Rank held Core Laboratories as of Q1 2020.

Based on Wolverine Trading's 13F filing for Q1 2020, filed 11 May 2020.